Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, CA 94305-5246.
R
R
Morishita
G H
GH
Gibbons
K E
KE
Ellison
M
M
Nakajima
H
H
von der Leyen
L
L
Zhang
Y
Y
Kaneda
T
T
Ogihara
V J
VJ
Dzau
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000818:Animals; D001483:Base Sequence; D016893:Carotid Stenosis / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D002453:Cell Cycle / Q000235:genetics*; D004195:Disease Models, Animal; D005809:Genes, Regulator; D015316:Genetic Therapy / Q000379:methods*; D008081:Liposomes; D008297:Male; D008969:Molecular Sequence Data; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage / Q000235:genetics* / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012008:Recurrence
D008081:Liposomes; D016376:Oligonucleotides, Antisense